Work where the world comes to think, discover and learn. There are thousands of faculty and staff members across our three campuses supporting our mission of research, teaching and scholarship.
The bulletin brief
Get faculty and staff news delivered straight to your inbox.
The Bulletin Brief is the latest iteration in a 75-year tradition of news for U of T staff and faculty. Get important information and see how we are impacting the communities we serve.About the Bulletin Brief
A focus on our people
Startup based on U of T researchers' work raises US$42 million to alleviate congested wireless networks
A Canadian semiconductor startup based on technology developed in the lab of the University of Toronto’s Sorin Voinigescu has raised US$42 million to help alleviate increasingly congested wireless networks.
The latest round of financing, which brings the total raised to over US$110 million, promises to help Toronto-based Peraso Technologies further develop its chips for the 60 gigahertz (GHz) band, which allows more data to be pushed through wireless hotspots for applications like streamed 4K television or virtual reality.
Members of the University of Toronto Faculty Association and the United Steelworkers Local 1998 have voted to support the University Pension Plan (UPP) Ontario, moving the university sector closer to a new multi-employer, jointly sponsored pension plan.
University of Toronto Faculty Association (UTFA) and United Steelworkers (USW) Local 1998 members voted strongly in favour of the UPP.
This means that UTFA and USW Local 1998 will provide consent to the proposed UPP on behalf of the members of the University of Toronto Pension Plan whom they represent.
Parkinson’s disease and Amyotrophic Lateral Sclerosis, or ALS, are the newest frontiers for open science drug discovery, a global movement led by University of Toronto researchers that puts knowledge sharing and medication affordability ahead of patents and profits.
Thanks to $1.5 million from Toronto’s Krembil Foundation, Medicines 4 Neurodegenerative Diseases, also known as M4ND Pharma, will pursue promising new genetic drug targets for these intractable nervous system disorders.
U of T is one of Canada’s top employers